>>> WELCOME BACK, EVERYONE.
THERE IS MORE GOOD NEWS IN THE
DEVELOPMENT OF A VACCINE.
MODERNA SAYS THEY HAVE REACHED
PHASE 3 OF THEIR TRIALS.
THEY SAY THEIR VACCINE IS MORE
THAN 93% EFFECTIVE.
THE FIRST 20 MILLION DOSES COULD
BE ROLLED OUT AS SOON AS NEXT
MONTH.
>> I HOPE IT MEANS THAT WE’RE
GOING TO BEAT THIS THING SOONER
RATHER THAN LATER.
THE TRUTH IS THERE IS STILL A
LOT OF WORK TO GET THERE.
THERE IT IS AN IMPORTANT
MILESTONE.
WE KNOW WE CAN PROTECT IT
AGAINST COVID-19.
WE NOW NEED TO MANUFACTURE THOSE
DOSES, MILLIONS AND MILLIONS OF DOSES AS WELL AS MAKE SURE
DOSES AS WELL AS MAKE SURE
THEY’RE DISTRIBUTED TO PEOPLE IN
NEED.
>> JOINING ME NOW IS A PROFESSOR OF EPIDEMIOLOGY.
OF EPIDEMIOLOGY.
ANOTHER DAY OF GOOD NEWS.
WE HAVE 90 ACCOUNT EFFICACY IN
THIS TRIAL.
TELL ME ABOUT THE DISDINGESTINCT
THESE VACCINES.
>> WE HAVE GREAT NEWS.
WE HAVE TWO VACCINES THAT SHOWED
FANTASTIC EFFICACY.
FAR BEYOND THE BENCH MAR, FAR
BEYOND THAT, WHICH IS ALL GREAT
NEWS IN TERMS OF WHAT IT COULD
MEAN IN TERMS OF EFFICACY, IN
THE POPULATION, AND HOW AND WHAT
WOULD NEED TO ACHIEVE HERD
IMMUNITY.
THE PFIZER VACCINE HAT 90%
EFFICACY.
MODERNA HAS 94.5% EFFICACY, BUT
WHAT IS REALLY, REALLY
INTERESTING ABOUT THE MODERNA
VACCINE IS IT DOESN’T REQUIRE
THAT REALLY COLD TEMPERATURE FOR
STORAGE.
IN FACT, REGULAR FREEZERS THAT
YOU FIND IN CLINICS AND
HOSPITALS AROUND THE UNITED
STATES AND THE WORLD CAN BE
USED.
IN FACT THAT MODERNA VACCINE CAN
BE AT ROOM TEMPERATURE FOR 12
HOURS IN IS A GAME CHANGER.
WE HAVE BEEN TALKING ABOUT HOW
WE NEED MINUS 94 DEGREE
FAHRENHEIT FREEZERS ALL OVER THE
UNITED STATES WHICH MAKES IT
DIFFERENT FOR RURAL AREAS,
PLACES WITHOUT GOOD RESOURCES IN
PLACE TO GET THAT VACCINE OUT IN
IS A VERY BIG DISTINCTION.
THE OTHER BIG DISTINCTION IS
THAT MODERNA RELEASED
INFORMATION ON THE DEMOGRAPHICS
ON THE POPULATION.
PEOPLE OF COLOR WELL REPRESENTED
AS WELL AS PEOPLE OVER AGE 65.
ALL VETERAN IMPORTANT.
I WANT FOLKS TO REALLY
UNDERSTAND THIS.
I HAD AN E-MAIL FROM CVS SAID WE
WILL DISTRIBUTE THIS VACCINE
ONCE IT HITS THE OPEN MARKET.
LOCAL URGENT CARE FACILITIES,
PHARMACIES, THAT KIND OF THING
WILL BE ABLE TO CARRY A VACCINE
BECAUSE IT DOESN’T HAVE TO BE
FROZEN AT THAT LEVEL LIKE YOU
WERE TALKING ABOUT WHEN IT COMES
TO PFIZER?
>> THAT’S EXACTLY WHAT I MEAN IF
CAN BE KEPT FOR LONG TERM
STORAGE MINUS 20 DEGREES
CELSIUS.
THAT’S A STANDARD REALLY COLD
FREEZER THAT IS EASILY
ACCESSIBLE THAN THE MINUS 80
DEGREE CELSIUS FREEZERS THAT
PFIZER NEEDS.
CVS, RITEAID, THEY WILL BE ABLE
TO STOCK THIS VACCINE FOR 30
DAYS AND 12 HOURS AT ROOM
TEMPERATURE.
THAT IS REALLY, REALLY, REALLY
IMPORTANT TO PUSH IT OUT.
IT IS IMPORTANT ALSO TO REMEMBER
THAT THIS VACCINE WILL NOT BE
READILY AVAILABLE TO THE PUBLIC
UNTIL PROBABLY MID APRIL AT THE
EARLIEST AND IT WILL TAKE MONTHS
TO DISTRIBUTE THIS ACROSS THE
UNITED STATES.
>> EXPAND ON THAT.
DR. FAUCI SAID BY THE END OF
DECEMBER THERE COULD BE DOSES OF
VACCINES AVAILABLE.
HE WAS ALSO ASKED IF THEY COULD
END UP WITH TREE,HREE, FOUR, OR
VACCINES AND HE SAID IT IS
POSSIBLE.
WHAT IS THE POSSIBILITY THAT WE
COULD SEE MORE COMING OUT IN THE
NEXT COUPLE OF WEEKS, A.
AND B, WHEN WOULD THAT
AUTHORIZATION COME THROUGH WHEN
THEY COULD GET TO THE MARKET AND
GET TO THE HIGH-RISK PEOPLE?
>> SO IN TERMS OF WHAT NEEDS TO
HAPPEN NEXT TO GET IT TO THIS
EMERGENCY USE AUTHORIZATION,
BOTH GROUPS NEEDED TO GET TO
AROUND 150 PARTICIPANTS TO BE
ABLE TO HIT THAT MARK.
SO THAT WE ANTICIPATE WILL
HAPPEN IN THE COMING WEEKS WITH
THE UNFORTUNATE SPREAD OF THE
VIRUS THAT WE’RE SEEING ALL
THROUGHOUT THE UNITED STATES.
THERE ARE MORE CASES WHICH MEANS
THAT WE’RE GOING TO HAVE MORE
POSITIVE CASES IN THE PLACEBO
AND POTENTIALLY IN THE VACCINE
GROUPS AS WELL.
THAT WIL MAKE US GET TO THE
POINT WHERE WE CAN SUBMIT THE
EMERGENCY USE AUTHORIZATION.
ONCE OF THE FDA REVIEW THAT’S
DATA THEY WILL ISSUE THE
EMERGENCY USE AUTHORIZATION AND
THERE WILL BE WITH THE MODERNA
AND PFIZER VACCINES, THEY WILL
ABOUT ABOUT 40 MILLION DOSES
TOGETHER WHICH MEANS ABOUT 20
MILLION PEOPLE GETTING THE
VIRUS.
YOU TO HAVE TWO DOSES OF THE
VACCINE.
THROES BE PUSHED OUT TO NAME ARE
AT HIGH RISK AND HEALTH CARE
WORKERS FIRST.
THEN AS IT IS MANUFACTURED WE
WILL BE ABLE TO HAVE MORE
VACCINE AVAILABLE AND BY APRIL
THEY HOPE TO HAVE ENOUGH TO BE
ABLE TO START DISTRIBUTING TO
THE AMERICAN PUBLIC.
I THINK THE OTHER THING TO KEEP
IN MIND IS THAT DISTRIBUTING THE
VACCINES WILL NOT BE EASY EVEN
IF THE REFRIGERATION IS
APPROPRIATE.
THIS MRNA VACCINE TECHNOLOGY, A
NEW TECHNOLOGY, IT TARGETS THE
SPIKE PROTEIN, WHICH IS VERY
IMPORTANT HERE IF SHOWS THIS
VACCINE TECHNOLOGY IS WORKING.
THAT IS REALLY GOOD FOR SEVERAL
VACCINE CANDIDATES.
AND WE MAY HAVE OHS USED MORE
TRADITIONAL TECHNOLOGY AS
WELCOMING DOWN THE PIPE.
IDEALLY WE’LL HAVE MANY
DIFFERENT VACCINE THAT’S WILL
AVAILABLE BY THE TIME WE’RE ABLE
TO START DISTRIBUTING THAT AND N
MAYBE APRIL.
>> LET’S HOPE THE GOOD NEWS